Health Canada announced the approval Wednesday after scientists finished a two-month review of the company's clinical trial data.

"The data provided supports favourably the efficacy of Pfizer-BioNTech COVID-19 vaccine as well as its safety," the department said in its report authorizing use in Canada.

https://www.cbc.ca/news/politics/vaccine-rollout-plan-phac-1.5833912